During the past decade, Kyung Hee University Hospital conducted 164 clinical trials. In the 10-year time frame, 164 clinical trials started and 42 clinical trials were completed, i.e. on average, 25.6% percent of trials that started reached the finish line to date. In the past 5 years, 62 clinical trials started and 31 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kyung Hee University Hospital" #1 sponsor was "Kyunghee University Medical Center" with 29 trials, followed by "Hoffmann-La Roche" with 13 trials sponsored, "Pfizer" with 11 trials sponsored, "Chong Kun Dang Pharmaceutical" with 10 trials sponsored and "Eli Lilly and Company" with 10 trials sponsored. Other sponsors include 165 different institutions and companies that sponsored additional 97 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kyung Hee University Hospital" #1 collaborator was "Kyunghee University Medical Center" with 13 trials as a collaborator, "Korea University Guro Hospital" with 10 trials as a collaborator, "Hanyang University" with 8 trials as a collaborator, "Inha University Hospital" with 8 trials as a collaborator and "Seoul National University Hospital" with 8 trials as a collaborator. Other collaborators include 260 different institutions and companies that were collaborators in the rest 149 trials.

According to Clinical.Site data, the most researched conditions in "Kyung Hee University Hospital" are "Ulcerative Colitis" (19 trials), "Crohn's Disease" (14 trials), "Coronary Artery Disease" (10 trials), "Rheumatoid Arthritis" (10 trials) and "Colitis, Ulcerative" (8 trials). Many other conditions were trialed in "Kyung Hee University Hospital" in a lesser frequency.

Most popular intervention types in "Kyung Hee University Hospital" are "Drug" (171 trials), "Device" (26 trials), "Other" (18 trials), "Procedure" (17 trials) and "Biological" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (55 trials), "Faricimab" (6 trials), "Mirikizumab" (6 trials), "Sham Procedure" (6 trials) and "Clopidogrel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Kyung Hee University Hospital" are 238 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are 55 active trials in "Kyung Hee University Hospital". 1 are not yet recruiting, 32 are recruiting, 21 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 133 completed trials in Kyung Hee University Hospital, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Kyung Hee University Hospital, 4 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 50 trials, and there were also 28 trials that are defined as “Not Applicable".